Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Robinson

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
The New England Journal of Medicine|October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid CancerJulien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Cancer Research|October 20, 2004
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.
Cancer Cell|October 19, 2013
The role of Cdk5 in neuroendocrine thyroid cancerKarine Pozo, Emely Castro-Rivera, Chunfeng Tan, et al.
The American Journal of Surgical Pathology|January 12, 2018
Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic FeaturesAnthony J Gill, Grace Lim, Veronica K Y Cheung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid CarcinomaAngela Chou, Min Ru Qiu, Henry Crayton, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2014
Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and EuropeAlexander Hamilton, Paul R Newby, Jacqueline D Carr-Smith, et al.
Plos Genetics|August 17, 2005
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomasPatricia L M Dahia, Ken N Ross, Matthew E Wright, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2020
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven MalignanciesBenjamin J Solomon, Lavinia Tan, Jessica J Lin, et al.
Histopathology|January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinomaYagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
The American Journal of Surgical Pathology|July 16, 2014
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patientsAnthony J Gill, Ondrej Hes, Thomas Papathomas, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
The New England Journal of Medicine|October 23, 2023
Phase 3 Trial of Selpercatinib in Advanced <i>RET</i>-Mutant Medullary Thyroid CancerJulien Hadoux, Rossella Elisei, Marcia S Brose, et al.
Cancer Research|October 20, 2004
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.
Cancer Cell|October 19, 2013
The role of Cdk5 in neuroendocrine thyroid cancerKarine Pozo, Emely Castro-Rivera, Chunfeng Tan, et al.
The American Journal of Surgical Pathology|January 12, 2018
Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic FeaturesAnthony J Gill, Grace Lim, Veronica K Y Cheung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 16, 2023
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid CarcinomaAngela Chou, Min Ru Qiu, Henry Crayton, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2014
Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and EuropeAlexander Hamilton, Paul R Newby, Jacqueline D Carr-Smith, et al.
Plos Genetics|August 17, 2005
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomasPatricia L M Dahia, Ken N Ross, Matthew E Wright, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2020
RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven MalignanciesBenjamin J Solomon, Lavinia Tan, Jessica J Lin, et al.
Histopathology|January 22, 2024
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinomaYagiz A Aksoy, Bin Xu, Kartik Viswanathan, et al.
The American Journal of Surgical Pathology|July 16, 2014
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patientsAnthony J Gill, Ondrej Hes, Thomas Papathomas, et al.
Pageof 15